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Background: Suicidal behaviours and non-suicidal self-harm (NSSH) are global public health concerns which 
affect millions of lives. Sources of data: This review is a narrative synthesis of systematic reviews, meta-
analyses of randomised control trials (RCTs) and landmark studies published in scientific journals. 
Areas of agreement: Restricting access to lethal means reduces the likelihood of future suicide deaths. 
Areas of controversy: Our ability to predict future suicidal behaviour is no better than chance. No individual 
risk prediction instrument offers sufficient sensitivity and specificity to inform clinically useful decision-
making. Growing points: Different types of psychosocial interventions may be effective in preventing future 
suicide attempts; such interventions include clinical assessment, tailored crisis response and safety plans, and 
follow-up contact. Areas timely for developing research: While some psychosocial interventions can be 
effective in reducing suicide risk, little is known about the mechanisms of recovery from suicidal thoughts and 
behaviours. 
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Figure 1. Iceberg model: 
Representation of the 
relative prevalence self-
harm and suicide in 
young people (5). 
The extent and challenge of suicide and 
suicidal behaviour 
 
Suicidal behaviours and non-suicidal self-
harm (NSSH) are global public health concerns 
which affect millions of lives (1). One of the 
challenges facing research and clinical practice 
concerns the categorical conceptualisation of self-
harm as either being suicidal or non-suicidal. The 
reality is that such behaviours often span both 
categories (2), and an individual’s reasons for 
engaging in self-injury are usually many and change 
over time (3). Additionally, perceived “desire to 
die” associated with the episode is also transient, 
fluctuating from moment to moment. In light of 
this, and consistent with the UK national clinical 
guidance, the term self-harm is used herein to refer 
to any act of self-poisoning or self-injury 
irrespective of the apparent motivation (4). 
However, when reporting on the research 
literature, the terminology used by the original 
authors will be maintained, where appropriate, so 
as not to misrepresent their findings. In addition, 
where we use the term suicide attempt or suicidal 
behaviour, there has been evidence of suicidal 
intent. 
An additional consideration in fully 
understanding the extent of self-harm is that self-
harm fits an iceberg model (Figure 1) (5). As 
detailed in Figure 1, the iceberg consists of three 
levels where suicide deaths (visible and relatively 
rare) make up the tip of the iceberg. The other 
observable part of the iceberg is made up of 
incidences of self-harm where the individual 
presents to clinical services, including general 
hospitals. The third level submerged, largely 
hidden, part of the iceberg represents self-harm 
which occurs in the community, which does not 
receive hospital treatment and which is often 
hidden. 
According to current estimates, around 
804,000 people die by suicide globally each year, 
and the number of people who attempt suicide or 
engage in NSSH is around 20 times higher than 
that of fatal suicides (1). Additionally, a recent 
population-based study of 18-34 year olds in 
Scotland found that 1 in 9 (11.3%) young people 
reported having made a suicide attempt whilst 1 in 
6 had engaged in NSSH (16.2%) (6). In this latter 
study over 50% of those who reported a past 
suicide attempt also had a history of self-harm, and 
this was more pronounced for women (6).  First 
onset of both NSSH and suicide attempt is younger 
in girls than boys (7).  
 
Hospital Presentations for Self-harm 
 
Due to between and within country 
differences in recording self-harm presentations to 
hospitals, it is difficult to accurately estimate the 
self-harm rates (1). One study estimated that the 
routinely collected data in England underestimated 
the overall hospital-treated rates of self-harm by 
approximately 60% (8). Findings from the Adult 
Psychiatric Morbidity Survey (2014) in England 
indicated that only a quarter (24.4%) of 
individuals who had engaged in self-harm reported 
attending hospital for their most recent episode 
(9). 
Self-harm can reoccur in the months 
following an index episode with studies estimating 
that around 16% of patients will engage in non-
fatal self-harm in the following 12 months (10,11) 
while between 2-7% of people die by suicide in the 
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following 1-9 years (10,11). The risk for individuals 
who attend an emergency department for 
treatment after attempting suicide is even higher. 
This group have a 16.3% increased risk of making 
another suicide attempt and a 3.9 % risk of dying 
by suicide within 5 years (12). Receiving hospital 
treatment for any self-harm is strongly associated 
with future suicide (13) with individuals who 
present to hospital with self-harm being 30 times 
more likely to die by suicide than those in the 
general population (14). Recent data in the UK 
(15), for example, has indicated that 88% of female 
patients aged under 25 who died by suicide had a 
history of self-harm. 
While suicides still occur in clinical care, 
the National Confidential Inquiry into Suicide and 
Safety in Mental Health indicated that in the UK 
rates have reduced throughout the last decade (15). 
Data from this report indicated that in the UK 
alone 14% of all patient suicides (n = 206) occurred 
within 3 months of receiving hospital treatment for 
self-harm. The highest suicide risk was in the first 
1-2 weeks after discharge and the highest number 
of deaths occurred on day 3 post-discharge. Risk of 
suicide is also high in the 30 days following 
discharge from psychiatric inpatient care (16); men 
with a diagnosis of depression and stress reactions 
are at highest risk of suicide following discharge. 
To date, having engaged in self-harm with or 
without suicidal intent is the most consistent 
predictor of a future suicide attempt (17,18). 
Although our understanding of some of the major 
risk factors for suicide has increased in recent years 
(13) our knowledge of specific indicators of risk 
remains fairly limited (19), making it difficult to 
identify individuals within high risk groups who 
are at particularly high risk of taking their own 
lives than others (20). 
 
From thoughts to actions: psychological 
processes and suicide risk 
 
 It is well established that mental illness 
increases risk of suicide, with retrospective studies 
suggesting that as many as 90% of those who die 
by suicide have a diagnosable psychiatric disorder 
(21). However, given that the overwhelming 
majority of people with a mental illness will never 
die by suicide, this is not a sufficient marker of risk 
(22). Therefore, from a clinician’s perspective, 
there is considerable utility in identifying factors 
that are associated with the development and 
emergence of suicide risk over and above 
psychiatric symptoms. The challenge, though, is 
that a combination of social, biological and 
psychological variables may act to increase or 
decrease risk of suicide (23); creating a complex 
picture of risk and protective factors that may 
individually only have small associations with the 
relatively rare phenomenon of suicide (19,22). 
To aid prediction and to improve 
treatment, a number of psychological models have 
been developed that aim to advance understanding 
of how this multitude of risk factors combine to 
increase suicide risk (23). Such models have 
identified the common factors and pathways 
involved in the emergence of suicidal ideation and 
suicidal behaviour. Crucially though, they have 
also focused on the factors which govern the 
transition from thinking about suicide to 
attempting suicide (20). Such models are set 
within the ideation-to-action framework, which 
posits that the factors associated with the 
emergence of suicidal ideation versus those 
associated with engaging in suicidal behaviour are 
distinct, yet overlapping, processes (24). 
The interpersonal theory of suicide (IPT) 
(25) was the first to consider suicide within this 
framework, suggesting that suicidal ideation is 
driven by perceived burdensomeness and thwarted 
belongingness, but that individuals also had to 
possess the capability to harm themselves to 
actually attempt suicide. This capability comprises 
a fearlessness about death and a tolerance for 
physical pain that helps an individual override 
their self-preservation instincts (26). More 
recently, O’Connor proposed the integrated 
motivational-volitional (IMV) model of suicidal 
behaviour (20). A central premise of the IMV 
model is that additional factors may aid the 
transition from suicidal ideation to suicidal 
behaviour (20). The IMV model proposes that 
feeling defeated and trapped by life circumstances 
are key to the emergence of suicidal ideation, and 
outlines volitional moderators that increase the 
likelihood that someone acts on their suicidal 
thoughts (Figure 2). Volitional factors may work 
by making suicide more accessible or cognitively 
available, and therefore more likely to be enacted 
(27). 
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Figure 2. Volitional 
moderators: factors that 
increase the risk of 
transition from suicidal 
ideation to suicidal 
behaviour according to 
the IMV model (20). 
Past suicidal behaviour is an important 
predictor of a future suicide attempt (28), with 
evidence that even one past suicide attempt is 
associated with an increased risk of repetition (5). 
Exposure to the suicidal behaviour of others (i.e., 
knowing someone who has attempted suicide or 
died by suicide) also appears to incur a particular 
risk; a recent birth cohort study found that 
adolescents who had made a suicide attempt were 
around five times more likely to have had a friend 
or family member who had a history of self-harm 
compared to adolescents who reported suicidal 
ideation only (29). Additionally, the experience of 
mental imagery of death increases suicide risk, 
potentially acting as a cognitive rehearsal for 
suicidal behaviour (30). Indeed, a growing body of 
research has shown that these volitional factors 
differentiate between those who have thoughts of 
suicide from those who have acted on those 
thoughts (29,31,32). In a comprehensive test of the 
volitional factors, young adults who had made a 
suicide attempt, compared to those who had 
suicidal thoughts only, scored higher on measures 
of acquired capability, impulsivity, mental imagery 
of death and more likely to have a friend who had 
made a suicide attempt, with no differences found 
on depressive symptoms (7). 
Evidence for how the volitional factors 
operate over time requires further longitudinal 
research to establish causality. This may be aided 
by the utilisation of new technologies within 
suicide research, which are uncovering the 
complex aspects of the development and 
emergence of suicidal ideation and behaviour. For 
example, harnessing smartphone technology using 
Ecological Momentary Assessment (EMA) (33), 
where participants track their thoughts, feelings 
and behaviours in real-time (usually multiple times 
a day over a week) using an app on their 
smartphone or watch, is growing in utility. EMA 
methodologies have been shown to be acceptable 
for use in suicidal samples (33), and findings have 
shown that suicidal ideation varies and fluctuates 
very differently across individuals who may score 
similarly on established measures of suicide risk 
(34). From a clinician’s perspective, gaining an 
understanding of a patient’s own unique suicidal 
experiences may be informative when evaluating 
suicide risk, and could help inform treatment. 
 
Clinical decision-making and the 
problems with predictive instruments 
for suicide risk assessment 
 
Healthcare settings, whether primary, 
acute or community-based, represent an important 
opportunity to identify and prevent suicide in 
those who are vulnerable. Suicide risk assessments 
in clinical settings are concerned with identifying 
and weighing up patient information to determine 
the extent to which an individual is vulnerable to 
suicidal behaviour and may require further 
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treatment or care. In busy clinical environments, 
assessment of suicide risk may be strongly 
influenced by time demands and therefore focus on 
the presence and strength of risk factors 
considered to be most strongly predictive of 
suicide. Unfortunately, reviews of the evidence 
confirm that our ability to predict future suicidal 
behaviour is poor (19). Even well-established risk 
factors such as prior suicidal ideation and 
behaviour, self-harm and psychopathology tend 
not to improve prediction of future suicide beyond 
chance (18,19). 
 Evidence for the use of risk prediction 
scales, where typically we classify individuals into 
risk strata (e.g., ‘high’ vs. ‘low’) based on clinician 
or patient ratings across various indicators, is also 
weak. For example, a meta-analysis of 21 
prospective cohort studies found that common risk 
prediction scales varied substantially in their levels 
of sensitivity (0.15 - 0.97) and specificity (0.17 – 
0.97) for accurately identifying those who will go 
on to engage in suicidal behaviour and those who 
will not (35). From these analyses it was concluded 
that no individual risk prediction scale offered 
sufficient sensitivity and specificity to inform 
clinically useful decision making (35). Other tests 
of diagnostic accuracy which are informative for 
clinical decision making also do not support the 
clinical utility of risk prediction scales: a meta-
analysis of 70 studies found that pooled positive 
predictive values (i.e. the probability that a person 
classified as high risk subsequently experiences the 
outcome) of risk prediction scales were just 6% for 
suicide and 36% for suicide and self-harm 
combined (36). Based on this analysis more than 
90% of those classified on the basis of risk 
prediction scales as being at high risk for future 
suicide do not engage in suicidal behaviour 
subsequently. 
 Although risk prediction scales ostensibly 
offer reassurance to clinicians and service 
providers, this reassurance is likely misplaced. The 
potential consequences of utilising risk prediction 
scales with demonstrably poor diagnostic accuracy 
in the clinical setting is significant: some individual 
scales will miss large numbers of those vulnerable 
to future suicidal behaviour, and therefore the 
opportunity to offer intervention and treatment to 
those who need it; furthermore, most scales will 
yield unacceptably high rates of false positives, 
leading to unnecessary treatment and clinical 
intervention in those who will receive no benefit 
(36,37). The limited clinical utility of risk 
prediction scales is also unlikely to be addressed 
through further refinement or development of 
existing or new scales, in large part because the 
low event rate of suicidal behaviour imposes a 
ceiling effect on the predictive accuracy of risk 
scales which falls short of those required to inform 




 The use of standard risk prediction scales 
or assessment of defined risk factors should not be 
used in isolation as the basis for determining 
further treatment or care (4). Current guidance 
explicitly recommends that integrated 
psychosocial assessments of individual needs and 
risk should be offered, which are grounded in the 
experiences and circumstances of the individual 
and should serve to engage the individual in any 
further assessment and treatment (4). Evidence 
suggests that a psychosocial assessment is 
associated with reduced risk of self-harm 
repetition (38,39). 
 Assessments of this kind are significantly 
broader in scope than standalone risk assessments 
and should cover key strengths and vulnerabilities, 
including any assets and support available, in 
addition to assessing risk and protective factors for 
future suicide. Important topics to cover include 
histories of physical and mental health, life 
stressors including social and financial 
circumstances, available support options and 
coping strategies and interpersonal relationships. 
The ‘risk assessment’ aspect of this integrated 
assessment should reflect the individual’s own 
experiences and explore sensitively those risk and 
protective factors that are known to contribute or 
mitigate future suicide risk. Although key risk 
factors, such as history of self-harm and suicidal 
behaviour, suicidal ideation, and symptoms of low 
mood, should feature prominently a more nuanced 
assessment which moves beyond the presence or 
absence of various factors will provide a richer 
assessment of an individual’s situation and risk.  
Particular attention may be given to those 
risk and protective factors that are potentially 
modifiable, given the potential to set in place risk 
reduction strategies. The emerging picture of an 
individual’s needs, strengths and vulnerabilities 
may be further tuned to reducing individual risk by 
considering combinations of factors and their 
relationships to different dimensions of suicide risk 
(20,40). For example, symptoms of low mood are 
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strongly related to the emergence of suicidal 
ideation but are less crucial in the transition to 
suicidal acts, whereas the presence of a plan to end 
one’s life or exposure to suicidal behaviour are 
more closely linked to the transition from suicidal 
thinking to suicidal behaviour (20). Careful 
assessment of such modifiable risk factors and 
their relationship to different dimensions of 
suicidal risk can enable more targeted risk 
reduction and treatment strategies. 
 Finally, because suicidal individuals often 
report mixed experiences of the care and support 
received in clinical settings (41) psychosocial 
assessments offer an opportunity to engage 
compassionately with individuals (4). For 
example, reviews have found that negatively 
evaluated experiences of psychosocial assessments 
are based on perceptions that the assessment feels 
superficial and rushed (41). In contrast, positive 
experiences are reported by patients who 
understood the intended purpose and aims of the 
assessment and who are given the opportunity to 
understand and share in decision-making about 
their care and support (41). 
 
Psychosocial interventions and suicide 
risk 
 
In recent years, there has been a growth in 
evidence for psychosocial assessment interventions 
that are effective in reducing suicidal thoughts and 
behaviours including: brief contact psychosocial 
interventions (42,43), multisession psychological 
treatments (44,45), and single-session crisis 
response planning (46). Although these are 
different types of intervention, it is possible to 
identify common elements across them. These are: 
1) clinical assessment, 2) tailored crisis response 
and safety plan, and 3) follow-up contact. As a 
detailed critique of the evidence is out of the scope 
of this review, this section will focus on some of 
the key components of psychosocial interventions 
that may be useful for medical staff. For a detailed 
and systematic critique of the evidence, see 
(42,45,47–49). In this section, we briefly describe 
the supporting evidence for those elements and 
summarise their dimensions and clinical 




Clinical assessment is a key component of 
treatment for suicide risk (Table 1). As 
recommended by the WHO (1) and NICE 
guidelines (4), clinical assessments should not rely 
on risk assessment tools, but rather on a detailed 
interview aiming to build a compassionate, 
trusting, supportive, and engaging relationship 
with the patient. This interview should facilitate 
the design of a person-centred comprehensive bio-
psycho-social risk mitigation plan which is 
personalised to the patient and their unique 
situation (50). Evidence suggests that these 
aspects are crucial to an effective clinical interview 
with suicidal patients (49). Assessing the patient’s 
history of suicidal thoughts and behaviours as well 
as self-harm is important as these are strongly 
associated with future suicide attempts (1). Such 
assessment includes asking directly about the 
specific components of suicide risk such as the 
characteristics of suicidal ideation (e.g., frequency 
of thoughts, the presence and details of a suicide 
plan and preparation), and access to lethal means 
of suicide (48,51). The clinician should also enquire 
about the current life/stressful events the patient is 
experiencing. This is essential to place the patient’s 
suicidal thoughts and behaviours into context and 
facilitating the understanding of proximal triggers 
and risk factors (52).  
Attention should also be given to how 
patients use the internet. Emerging evidence 
suggests that social media may be another factor 
associated with suicide and self-harm clustering 
(particularly among young people) through direct 
exposure to suicidal behaviour, through 
inappropriate media reporting, and the belief that 
suicidal behaviours are commonplace (53). 
Vulnerable individuals searching for suicide 
methods online, cyberbullying, and online 
gambling (54) also require consideration. Bearing 
in mind that this is now a patient safety issue, 
clinicians should consider how best to ask their 
patients about their internet use and digital help 
seeking (55).  
During the clinical interview, the clinician 
should address the barriers to a patient’s disclosure 
of suicidal thoughts, as evidence suggests that 
nearly 60% of people who go on to die by suicide 
have not expressed suicidal ideation at a specified 
earlier time (56). As some patients do not speak 
out fearing that this would result in their 
emotional pain being taken less seriously (57), a 
compassionate and trusting relationship may 
enable patients to openly talk about their feelings 
and, ultimately, about their suicidal thoughts (58). 
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Table 1. Summary of common elements of clinical assessment and interventions for suicide risk based on 
43,44,47,59,65. 
 
Intervention element Dimension Clinical Questions/Actions 
Clinical Assessment History of suicidal 
thoughts and 
behaviours 
1. Have you ever tried to take your own life or attempted 
suicide? 
2. Have you ever thought about taking your own life but 
have not attempted to do so? 
3. Have you lost someone by suicide? 
4. Have you ever harmed yourself without the intent to 
die? 
Suicidal ideation 1. When did you begin thinking about suicide? 
2. How often do you think about suicide? 
3. How long do these thoughts last? 
4. When/In which situations do these thoughts generally 
come? 
5. What do you do when you have these thoughts? 
Suicidal intent and 
preparation 
1. Have you formulated a plan to kill yourself? If yes, tell me 
the details of it. 
2. Have you made any preparations? If yes, tell me the 
details of it. 
3. How likely do you think you are to carry out your plan? 
Access to means 1. Do you have access to the methods for use in a suicide 
attempt? If yes, what are they and where are they? 
Stressful events and 
coping 
1. Have you experienced anything especially stressful 
recently? 
2. When you are felling distressed or emotionally unwell, 
how do you cope? 




1. Detail the warning signs: what are the thoughts, moods, 
images, behaviours, context, and other triggers that 
indicate that a crisis may be developing? 
Use of individual 
coping strategies 
2. List the activities that the patient can do to regulate 
their emotions and thoughts without contacting another 
person (e.g., distractions, relaxation techniques, physical 
activity). 
Interaction with 
people and social 
environments that 
provide distraction 
3. List the names and contact details for people and places 
that can provide distraction, without disclosing the 
feelings and thoughts of suicide. 
Contact people who 
can provide help 
4. List the names and contact details for closed ones (e.g., 
family and friends) with whom the patient is comfortable 





institutions that can 
help 
5. List the names and contact details for clinicians, suicide 
hotlines, and emergency departments that can provide help 




6. Discuss with the person and family members or closed 
ones about reducing access to lethal means of suicide (e.g., 
giving firearms away, reducing the amount of medication 
available). 
Reasons for living 7. List the names of things that are positive for the person 
and represent the reasons for them to be alive. 
Follow-up contact Establishing 
systematic follow-up 
contacts 
1. Establish follow-up appointments to update clinical 
assessments and revise the implementation of the crisis 
response and safety plan. 
2. Contact the patient through phone calls, letters, or post-
cards to demonstrate availability of health care and 
support.  
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Finally, enquiring about the individual’s 
coping responses to those events and their 
distressing emotional states is crucial to provide a 
sense of adaptive and maladaptive strategies and 
their effect on the increase or decrease of risk (59). 
The information gathered during the clinical 
assessment will provide a basis for the 
development of a collaboratively tailored crisis 
response and safety plan. 
 
Tailored Crisis Response and Safety Plan 
 
Developing a crisis response and safety 
plan is central for any effective intervention for 
suicide risk (Table 1). Although it has been given 
different labels (e.g., safety planning, coping plan, 
stabilisation plan, crisis response plan, risk 
management plan, etc.), a variant of it is present in 
most evidence-based interventions that have been 
shown to be effective in reducing risk of future 
suicidal behaviour. The development of a tailored 
crisis response and safety plan should be a 
collaborative exercise, helping the patient to 
identify triggering events and warning signs that 
may increase escalation of a crisis. It also provides 
an opportunity to identify strategies to help 
mitigate the psychological distress that may lead to 
a suicidal crisis. A key element of a safety plan is 
means safety. As methods of self-harm and suicide 
attempt may change and escalate to lethal means, it 
is advised that all patients should be routinely 
assessed (60) and means safety addressed (e.g., 
giving firearms away, reducing the amount of 
medication available). In addition to the crisis 
response or safety plan, it is important that 
clinicians help their patients to think about coping 
strategies to deal with psychological distress in 
general, not focusing only on the suicidal crisis. It 
is expected that clinicians and patients will 
collaboratively create a crisis response and safety 
plan and each one will keep a copy of the plan. 
Some patients find it helpful to keep the plan with 
them for easy access (e.g., photo of the plan on 
their mobile phone) in case they need it on their 
daily activities. For more information, see Stanley 




 Finally, follow-up contact is an imperative 
in the treatment of suicide risk (Table 1). Evidence 
suggests that making a series of active contact and 
follow-up interventions is associated with reduced 
likelihood of suicidal behaviour and future hospital 
presentation for self-harm, particularly during the 
first six months after discharge from an emergency 
department after a suicide attempt (61,62). 
Research suggests that the implementation of 
safety planning with at least two follow-up 
telephone calls is associated with a reduction in 
suicide attempts and improved treatment 
engagement for patients who had attempted 
suicide (63). In a large-scale study, researchers 
described their follow-up contact as telephone 
calls to monitor suicide risk, review, revise and 
discuss the patient’s experiences with the safety 
planning implementation (63). During the follow-
up contact, clinicians should be sensitive to the 
patient’s successes, but also to their difficulties 
related to the crisis response and safety plan. A 
feasibility study of delivering a similar safety 
planning and telephone support intervention has 




Suicidal behaviour remains one of the main 
challenging areas for treatment given its 
complexity and variability. Evidence suggests that 
traditional risk assessment exclusively based on 
standardised questionnaires of risk factors are of 
limited clinical utility. Instead, understanding the 
psychosocial factors associated with increase and 
reduction of suicide risk can be useful to plan 
effective treatment. Research shows that 
psychosocial interventions involving clinical 
assessment, tailored crisis response and safety 
plans, and follow-up contact can significantly 
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